These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis? Wong LL; Hegade VS; Jones DEJ Dig Dis; 2017; 35(4):359-366. PubMed ID: 28468009 [TBL] [Abstract][Full Text] [Related]
7. Primary biliary cholangitis: Old and novel therapy. Floreani A; Mangini C Eur J Intern Med; 2018 Jan; 47():1-5. PubMed ID: 28669591 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and Treatment of Primary Biliary Cholangitis]. Kim KA Korean J Gastroenterol; 2023 Feb; 81(2):86-90. PubMed ID: 36824036 [TBL] [Abstract][Full Text] [Related]
9. Current Status of Liver Transplantation for Primary Biliary Cholangitis. Aguilar MT; Carey EJ Clin Liver Dis; 2018 Aug; 22(3):613-624. PubMed ID: 30259857 [TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. Harms MH; van Buuren HR; Corpechot C; Thorburn D; Janssen HLA; Lindor KD; Hirschfield GM; Parés A; Floreani A; Mayo MJ; Invernizzi P; Battezzati PM; Nevens F; Ponsioen CY; Mason AL; Kowdley KV; Lammers WJ; Hansen BE; van der Meer AJ J Hepatol; 2019 Aug; 71(2):357-365. PubMed ID: 30980847 [TBL] [Abstract][Full Text] [Related]
11. A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA. Schattenberg JM; Pares A; Kowdley KV; Heneghan MA; Caldwell S; Pratt D; Bonder A; Hirschfield GM; Levy C; Vierling J; Jones D; Tailleux A; Staels B; Megnien S; Hanf R; Magrez D; Birman P; Luketic V J Hepatol; 2021 Jun; 74(6):1344-1354. PubMed ID: 33484775 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of ursodeoxycholic acid for primary biliary cholangitis: Experience from a tertiary care centre in Saudi Arabia. AlWabel AH; Peedikayil M; AlNasser S; AlHusaini K; AlHekail O; Alqahtani SA; AlTraif IH; AlAshgar H Saudi J Gastroenterol; 2023; 29(2):135-140. PubMed ID: 35229756 [TBL] [Abstract][Full Text] [Related]
13. Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems. Goel A; Kim WR Clin Liver Dis; 2018 Aug; 22(3):563-578. PubMed ID: 30259853 [TBL] [Abstract][Full Text] [Related]
14. Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open label pilot study. Wunsch E; Raszeja-Wyszomirska J; Barbier O; Milkiewicz M; Krawczyk M; Milkiewicz P J Gastrointestin Liver Dis; 2018 Sep; 27(3):273-279. PubMed ID: 30240471 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of primary biliary cholangitis. Laschtowitz A; de Veer RC; Van der Meer AJ; Schramm C United European Gastroenterol J; 2020 Jul; 8(6):667-674. PubMed ID: 32299307 [TBL] [Abstract][Full Text] [Related]
17. New Therapies on the Horizon for Primary Biliary Cholangitis. Tanaka A Drugs; 2024 Jan; 84(1):1-15. PubMed ID: 38082142 [TBL] [Abstract][Full Text] [Related]
18. Old and new treatments for primary biliary cholangitis. Chascsa D; Carey EJ; Lindor KD Liver Int; 2017 Apr; 37(4):490-499. PubMed ID: 28371104 [TBL] [Abstract][Full Text] [Related]
19. [An interpretation of 2017 EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis]. Han Y; Chen Y Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):814-818. PubMed ID: 29325274 [TBL] [Abstract][Full Text] [Related]
20. Definition and Management of Patients With Primary Biliary Cholangitis and an Incomplete Response to Therapy. Montano-Loza AJ; Corpechot C Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2241-2251.e1. PubMed ID: 32629125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]